Trial intelligence / Profile preview

Subcutaneous tramadol pharmacokinetics in ICU step-down patients receiving PCA fentanyl

ACTRN12611001018909Phase 4Completed

Sponsor
Guy Ludbrook
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of tramadol in acute pain, sponsored by Guy Ludbrook. Primary endpoint: Rate of absorption of subcutaneous tramadol at 24 hours. Started Apr 2010; status: completed.

02

Drugs

tramadol
03

Conditions

acute pain

Beyond the preview

Go deeper on ACTRN12611001018909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611001018909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call